Clitoral atrophy involves the clitoris shrinking in size, losing its normal fullness, and becoming less visible or harder to locate beneath the clitoral hood. The tissue may appear pale, thinner, and less defined than it once was. These changes happen gradually, often over months or years, which makes them easy to miss until symptoms like reduced sensation or discomfort during arousal become noticeable.
Visible and Physical Changes
The most recognizable sign is a reduction in the size of the clitoral glans, the small rounded tip visible at the top of the vulva. In healthy adult women, the glans typically measures about 3.4 mm across and 5.1 mm in length, with a total clitoral length (including the shaft beneath the skin) averaging around 16 mm. With atrophy, the glans can shrink noticeably from these baseline dimensions, and the tissue feels less firm or plump to the touch.
The surrounding tissue changes too. The clitoral hood may tighten and partially fuse to the glans, a condition called phimosis of the prepuce. When this happens, the hood no longer retracts easily, and the glans becomes difficult to see or expose. In some cases, adhesions form between the hood and the glans, trapping dead skin cells and natural oils underneath. These trapped deposits can harden into small, pearl-like bumps called keratin pearls, which sometimes cause localized pain or tenderness.
The vulvar skin around the clitoris often shows parallel changes. It may look pale, shiny, and dry rather than its usual pink or darker tone. Some women notice redness or tiny pinpoint spots (petechiae) if inflammation is present. The labia minora can recede or thin out, and the labia majora may lose their fullness as underlying fat and collagen decrease. Together, these changes give the entire vulvar area a flatter, smoother appearance with less defined contours.
What It Feels Like
The sensory changes are often what prompt women to notice something is wrong. Clitoral atrophy reduces the tissue’s ability to respond to touch and arousal. You may find that stimulation that was once pleasurable now feels muted or produces no sensation at all. The clitoris depends on healthy blood flow to engorge during arousal, and when the tissue thins and blood vessels diminish, that engorgement response weakens or disappears.
For some women, the experience flips in the opposite direction. Rather than numbness, they develop hypersensitivity or pain in the clitoral area, known as clitorodynia. This can happen when adhesions trap irritants against the glans or when thinning tissue leaves nerve endings closer to the surface. The result is that light contact or even clothing friction becomes uncomfortable. Difficulty reaching orgasm, or orgasms that feel significantly weaker than before, is another common report.
Dryness, burning, and itching in the broader vulvar and vaginal area frequently accompany clitoral changes, since the same hormonal shifts affect all of these tissues simultaneously.
Why It Happens
Estrogen is the primary driver. Estrogen receptors are concentrated throughout the vulva, vagina, urethra, and clitoris, where they maintain blood flow, tissue thickness, elasticity, and moisture. When estrogen levels drop, collagen production slows, the tissue’s outer layer thins, elastin decreases, and blood supply to the area diminishes. The tissue essentially loses its structural support.
Menopause is the most common trigger. About 40% to 60% of postmenopausal women develop some degree of genital atrophy, though the progression varies. One study tracking women over time found that only 4% experienced these changes during perimenopause, but that figure climbed to 25% within the first year after menopause and reached 47% by three years. Despite how common it is, relatively few women seek treatment.
Menopause isn’t the only cause. Diabetes can accelerate clitoral tissue changes. Research comparing clitoral smooth muscle thickness across different groups found that women with diabetes had some of the lowest measurements, even before menopause. Breastfeeding temporarily suppresses estrogen and can cause similar (usually reversible) changes. Certain cancer treatments, surgical removal of the ovaries, and some medications that lower estrogen levels can all contribute.
How Clitoral Adhesions Differ From Atrophy
Clitoral adhesions and atrophy overlap but aren’t identical. Adhesions specifically refer to the clitoral hood fusing or scarring to the glans, which can happen as a consequence of atrophy but also results from chronic skin conditions like lichen sclerosus, repeated infections, or inflammation. If you can no longer retract the hood at all, or if you notice small bumps or cyst-like formations under the hood, adhesions are likely involved.
Adhesions tend to produce more localized symptoms: sharp or burning pain at the clitoris, discomfort with direct contact, and difficulty with arousal. They can sometimes be resolved with careful manual separation or minor surgical procedures, while the underlying atrophy typically requires hormonal treatment to address.
Treatment and What to Expect
Topical estrogen applied directly to the vulvar area is the most established treatment. It works by restoring estrogen’s effects locally, rebuilding tissue thickness, improving blood flow, and reversing dryness. A typical approach involves daily application for the first two weeks, then tapering to twice weekly for maintenance. Many women notice improvements in comfort and moisture within a few weeks, though tissue rebuilding takes longer.
Research on testosterone applied to the skin has shown it can improve blood flow to the clitoris specifically. In studies of women with sexual dysfunction, transdermal testosterone gel increased clitoral blood flow measurements, which correlated with improved arousal response. This remains an off-label use, but it’s an option some specialists offer when estrogen alone doesn’t fully restore sensation.
Regular sexual stimulation, whether with a partner or alone, helps maintain blood flow to clitoral tissue and may slow the progression of atrophy. The principle is straightforward: tissue that receives consistent blood flow retains more of its health and responsiveness than tissue that doesn’t. Some clinicians recommend this as a complement to hormonal treatment rather than a standalone strategy, since stimulation alone can’t replace the structural role estrogen plays in maintaining collagen and elasticity.
Moisturizers designed for vulvar skin can help manage day-to-day dryness and irritation. These don’t reverse atrophy, but they reduce friction and discomfort while other treatments take effect. For women who cannot use hormonal therapies, non-hormonal vaginal moisturizers and lubricants during sexual activity remain the primary management tools.